Canagliflozin Increases Calorie Intake in Type 2 Diabetes Without Changing the Energy Ratio of the Three Macronutrients: CANA-K Study

Sodium/glucose cotransporter-2 (SGLT2) inhibitors improve glycemic control and reduce body weight by increasing glycosuria. Although a compensatory increase of food intake has been reported, the long-term effect of SGLT2 inhibitors on food intake remains unclear. This study investigated the influenc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes technology & therapeutics 2020-03, Vol.22 (3), p.228-234
Hauptverfasser:	Matsuba, Ikuro, Kanamori, Akira, Takihata, Masahiro, Takai, Masahiko, Maeda, Hajime, Kubota, Akira, Iemitsu, Kotaro, Umezawa, Shinichi, Obana, Mitsuo, Kaneshiro, Mizuki, Kawata, Takehiro, Takuma, Tetsuo, Takeda, Hiroshi, Machimura, Hideo, Mokubo, Atsuko, Motomiya, Tetsuya, Asakura, Taro, Kikuchi, Taisuke, Matsuzawa, Yoko, Ito, Shogo, Miyakawa, Masaaki, Terauchi, Yasuo, Tanaka, Yasushi
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antidiabetics Canagliflozin - pharmacology Diabetes Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diet Surveys Dietary Carbohydrates - blood Dietary Fats - blood Dietary Proteins - blood Energy Intake - drug effects Energy Metabolism - drug effects Female Glucose Glucose monitoring Glycated Hemoglobin A - analysis Hemoglobin Humans Hypoglycemic Agents - therapeutic use Inhibitor drugs Insulin - therapeutic use Male Middle Aged Nutrients - blood Nutrition Prospective Studies Sodium-Glucose Transporter 2 Inhibitors - pharmacology Weight Loss - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!